Literature DB >> 14715440

Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.

Richard M Kostrzewa1, Juan Segura-Aguilar.   

Abstract

Cellular mechanisms involved in neurodegeneration and neuroprotection are continuing to be explored, and this paper focuses on some novel discoveries that give further insight into these processes. Oligodendrocytes and activated astroglia are likely generators of the pro-inflammatory cytokines, such as the tumor necrosis factor family and interleukin family, and these glial support cells express adhesion receptors (e.g., VCAM) and release intercellular adhesion molecules (ICAM) that have a major role in neuronal apoptosis. Even brief exposure to some substances, in ontogeny and sometimes in adulthood, can have lasting effects on behaviors because of their prominent toxicity (e.g., NMDA receptor antagonists) or because they sensitize receptors (e.g., dopamine D2 agonists), possibly permanently, and thereby alter behavior for the lifespan. Cell cycle genes which may be derived from microglia, are the most-recent entry into the neuroprotection schema. Neuroprotection afforded by some common substances (e.g., melatonin) and uncommon substances [e.g., nicotine, green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG), trolox], ordinarily thought to be simple radical scavengers, now are thought to invoke previously unsuspected cellular mechanisms in the process of neuroprotection. Although Alzheimer's disease (AD) has features of a continuous spectrum of neural and functional decline, in vivo PET imaging and and functional magnetic resonance imaging, indicate that AD can be staged into an early phase treatable by inhibitors of beta and gamma secretase; and a late phase which may be more amenable to treatment by drugs that prevent or reverse tau phosphorylation. Neural transplantation, thought to be the last hope for neurally injured patients (e.g., Parkinsonians), may be displaced by non-neural tissue transplants (e.g., human umbilical cord blood; Sertoli cells) which seem to provide similar neurotrophic support and improved behavior - without posing the major ethical dilemma of removing tissue from aborted fetuses. The objective of this paper is to invite added research into the newly discovered (or postulated) novel mechanisms; and to stimulate discovery of additional mechanisms attending neurodegeneration and neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14715440     DOI: 10.1007/BF03033166

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.978


  89 in total

1.  7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats.

Authors:  J Oswiecimska; R Brus; R Szkilnik; P Nowak; R M Kostrzewa
Journal:  Pharmacol Biochem Behav       Date:  2000-09       Impact factor: 3.533

2.  Neonatal exposure to the glutamate receptor antagonist MK-801: effects on locomotor activity and pre-pulse inhibition before and after sexual maturity in rats.

Authors:  R. J. Beninger; A. Jhamandas; H. Aujla; L. Xue; R. V. Dagnone; R. J. Boegman; K. Jhamandas
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 3.  Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease.

Authors:  Julie K Andersen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

4.  G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis.

Authors:  D S Park; E J Morris; L A Greene; H M Geller
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

Review 5.  Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration.

Authors:  K Iqbal; A del C Alonso; E El-Akkad; C X Gong; N Haque; S Khatoon; I Tsujio; I Grundke-Iqbal
Journal:  J Neural Transm Suppl       Date:  2002

6.  Corticosterone down-regulates dopamine D4 receptor in a mouse cerebral cortex neuronal cell line.

Authors:  Virginia G Barros; Lorena A Boado; Ana M Adamo; Raúl Caviedes; Pablo Caviedes; Marta C Antonelli
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Cell culture protection and in vivo neuroprotective capacity of flavonoids.

Authors:  Federico Dajas; Felicia Rivera; Fernanda Blasina; Florencia Arredondo; Carolina Echeverry; Laura Lafon; Andrea Morquio; Horacio Heinzen; Horacio Heizen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity.

Authors:  R Aguilar Hernández; M J Sánchez De Las Matas; C Arriagada; C Barcia; P Caviedes; M T Herrero; J Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 9.  Parkinson's disease and inflammatory changes.

Authors:  Carlos Barcia; Andrés Fernández Barreiro; Máximo Poza; María-Trinidad Herrero
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Energy requirements for two aspects of phospholipid metabolism in mammalian brain.

Authors:  A D Purdon; S I Rapoport
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

View more
  24 in total

Review 1.  Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.

Authors:  Neeraj Joshi; Joyshree Biswas; C Nath; Sarika Singh
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

2.  Should we control the pineal status of patients following brain radiotherapy?

Authors:  Nelly Wion-Barbot; François Berger; Didier Wion
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 3.  Impact of the CD40-CD40L dyad in Alzheimer's disease.

Authors:  Brian Giunta; Kavon Rezai-Zadeh; Jun Tan
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

4.  Nicotine aggravates the brain postischemic inflammatory response.

Authors:  Shayna T Bradford; Svetlana M Stamatovic; Raj S Dondeti; Richard F Keep; Anuska V Andjelkovic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-14       Impact factor: 4.733

Review 5.  Environmental toxins and alpha-synuclein in Parkinson's disease.

Authors:  Yanying Liu; Hui Yang
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

6.  Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury.

Authors:  Tim West; Madeliene Atzeva; David M Holtzman
Journal:  Dev Neurosci       Date:  2007       Impact factor: 2.984

7.  Effects of lysophosphatidylcholine on beta-amyloid-induced neuronal apoptosis.

Authors:  Zhen-xia Qin; Hui-yan Zhu; Ying-he Hu
Journal:  Acta Pharmacol Sin       Date:  2009-04       Impact factor: 6.150

Review 8.  The antiapoptotic activity of melatonin in neurodegenerative diseases.

Authors:  Xin Wang
Journal:  CNS Neurosci Ther       Date:  2009-10-10       Impact factor: 5.243

9.  Improving active and passive avoidance memories deficits due to permanent cerebral ischemia by pomegranate seed extract in female rats.

Authors:  Alireza Sarkaki; Moslem Rezaiei; Mohammadkazem Gharib Naseri; Maryam Rafieirad
Journal:  Malays J Med Sci       Date:  2013-03

10.  Brain-region-specific astroglial responses in vitro after LPS exposure.

Authors:  Markus Kipp; Akvile Norkute; Sonja Johann; Leila Lorenz; Alena Braun; Andrea Hieble; Stefan Gingele; Friederike Pott; Janek Richter; Cordian Beyer
Journal:  J Mol Neurosci       Date:  2008-03-29       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.